खोज परिणाम - Lina Pugliano
- प्रदर्शित 1 - 3 परिणाम 3
-
1
-
2
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer द्वारा Stefan Michiels, Lina Pugliano, Sophie Marguet, Daniel Grun, Jana Barinoff, David Cameron, Melody A. Cobleigh, Angelo Di Leo, S. Johnston, Giulio Gasparini, Bella Kaufman, M Marty, Valentina Nekljudova, Shani Paluch–Shimon, F Penault–Llorca, Dennis J. Slamon, Charles L. Vogel, Gϋnter von Minckwitz, Marc Buyse, Martine Piccart
प्रकाशित 2016Artigo -
3
Clinical Oncology Society of Australia: Position statement on <scp>cancer‐related</scp> malnutrition and sarcopenia द्वारा Nicole Kiss, Jenelle Loeliger, Merran Findlay, Elisabeth Isenring, Brenton J. Baguley, Anna Boltong, Alexis Butler, Irene Deftereos, Michelle Eisenhuth, Steve F. Fraser, R. Fichera, Hayley Griffin, Sandra C. Hayes, Emily Jeffery, Catherine Johnson, Chris Lomma, Barbara S. van der Meij, Carolyn J. Peddle‐McIntyre, Tracey Nicholls, Lina Pugliano, Tina L. Skinner, Jane Stewart, Judith Bauer
प्रकाशित 2020Revisão
खोज साधन:
संबंधित विषय
Cancer
Internal medicine
Medicine
Breast cancer
Clinical trial
Oncology
Trastuzumab
Adverse effect
Clinical endpoint
Confidence interval
Family medicine
Hazard ratio
Intensive care medicine
Lapatinib
Malnutrition
Metastatic breast cancer
Multidisciplinary approach
Overall survival
Pertuzumab
Physical therapy
Position statement
Progression-free survival
Randomized controlled trial
Sarcopenia
Social science
Sociology
Surrogate endpoint
Tolerability